Trials
Search / Trial NCT06433206

Care Needs in Lung Cancer Patients Receiving Immunotherapy

Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · May 22, 2024

Apply for Trial

Trial Information

Current as of March 14, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying the care needs of lung cancer patients who are receiving immunotherapy, a newer type of treatment that helps the body's immune system fight cancer. Lung cancer is a serious condition and can be overwhelming, especially with new treatments that patients may not fully understand. The researchers want to find out how factors like a patient's overall health, mood, and personal circumstances affect their need for support and care. By understanding these connections, healthcare providers can better assist patients and improve their quality of life during treatment.

To participate in this study, individuals must be at least 20 years old and diagnosed with lung cancer. They should have either received immunotherapy in the past or be currently undergoing it. Participants will need to communicate in Mandarin or Taiwanese and be able to complete questionnaires about their experiences and needs. The findings from this trial aim to help nurses and caregivers provide more tailored support to lung cancer patients, ensuring they feel less anxious and more satisfied throughout their treatment journey.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • 1. Individuals diagnosed with malignant lung tumors based on imaging or post-surgical histopathological examination results by specialized physicians.
  • • 2. Individuals who have received immunotherapy in the past or are currently undergoing immunotherapy.
  • • 3. Research participants who are conscious, aged 20 years or older, able to communicate in Mandarin or Taiwanese, capable of completing the questionnaire, willing to participate in the study, and have signed the research consent form.
  • Exclusion Criteria:
  • • 1. Individuals with significant cognitive impairments who are unable to complete the questionnaire.
  • • 2. Individuals who are unable to communicate in Mandarin or Taiwanese.

Trial Officials

Meng Ping Hsiao, master

Principal Investigator

NTUCC

About National Taiwan University Hospital

National Taiwan University Hospital (NTUH) is a leading medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pioneer in medical education and patient care in Taiwan, NTUH integrates cutting-edge technology with comprehensive clinical expertise to facilitate groundbreaking studies across various medical fields. The hospital’s dedicated research team collaborates with local and international partners to enhance the understanding of diseases and improve treatment outcomes. By prioritizing patient safety and ethical standards, NTUH strives to contribute to the global medical community and foster advancements in healthcare practices.

Locations

Taipei, , Taiwan

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0